Reakcja alergiczna na domięśniowe podanie analogu GnRH u dziewczynki leczonej z powodu centralnego przedwczesnego pokwitania – opis przypadku
Przegląd Pediatryczny · 2026 · 55 (3) · 100-106
DOI: 10.26625/10269 ↗Kurz gefasst
Fachartikel in der Zeitschrift Przegląd Pediatryczny, 2026. Verfasst von Aleksandra Kamińska und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Central precocious puberty (CPP) may result in adverse auxological and psychosocial outcomes if left untreated. We present the case of a girl with CPP successfully treated with triptorelin who developed a delayed hypersensitivity reaction leading to premature discontinuation of therapy. The patient was born following a pregnancy complicated by gestational diabetes, maternal hypertension, and urinary tract infection. Her medical history included delayed speech development, swallowing difficulties, generalized hypotonia, PFO/ASD II, and genetically confirmed thrombophilia. Signs of puberty, including breast development, pubic hair growth, acne, oily hair, and accelerated growth velocity, appeared at approximately 7.5 years of age. At 9 years and 2 months, she underwent endocrine evaluation. Physical examination revealed Tanner stage P3/B3 development, and a GnRH stimulation test demonstrated a pubertal response. Bone age assessment and imaging findings supported the diagnosis of CPP, and treatment with triptorelin (Diphereline) was initiated within the national drug programme. After one year of therapy, clinical and ultrasonographic findings demonstrated effective suppression of pubertal progression, including stabilization of secondary sexual characteristics, reduction in uterine size, and slowing of bone maturation. However, after approximately 18 months of treatment, the patient developed a delayed local hypersensitivity reaction characterized by erythema, pruritus, and swelling at the injection site several hours after administration. The reaction recurred following a subsequent dose administered under hospital supervision, confirming triptorelin hypersensitivity. Consequently, treatment was discontinued before the planned therapeutic endpoint had been achieved. This case demonstrates the efficacy of GnRH analogue therapy in CPP and highlights the importance of recognizing rare hypersensitivity reactions that may necessitate treatment cessation.
Zitieren
APA
Kamińska, A., Alska, A., & Myśliwiec, M. (2026). Reakcja alergiczna na domięśniowe podanie analogu GnRH u dziewczynki leczonej z powodu centralnego przedwczesnego pokwitania – opis przypadku. Przegląd Pediatryczny, 55(3), 100-106. https://doi.org/10.26625/10269
Vancouver
Kamińska A, Alska A, Myśliwiec M. Reakcja alergiczna na domięśniowe podanie analogu GnRH u dziewczynki leczonej z powodu centralnego przedwczesnego pokwitania – opis przypadku. Przegląd Pediatryczny. 2026;55(3):100-106. doi:10.26625/10269
BibTeX
@article{Kamiska2026,
author = {Kamińska, Aleksandra and Alska, Anna and Myśliwiec, Małgorzata},
title = {Reakcja alergiczna na domięśniowe podanie analogu GnRH u dziewczynki leczonej z powodu centralnego przedwczesnego pokwitania – opis przypadku},
journal = {Przegląd Pediatryczny},
year = {2026},
volume = {55},
number = {3},
pages = {100--106},
doi = {10.26625/10269}
}
EUVIMED